For example, Melo et al. reported that pancreatic cancer cell-derived exosomes were enriched with glypican-1, and that glypican-1-positive circulating exosomes could be a potential diagnostic biomarker for early-stage pancreatic cancer [24]. This evidence concerns the gene GPC1 and familial pancreatic carcinoma.